Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

Purpose: During the SARS-CoV-2 pandemic, national and international societies have recommended continuing biological agents in patients with immune-mediated inflammatory diseases (IMID) in the absence of SARS-CoV-2 symptoms. However, adherence to biological treatment might decrease, because these recommendations contradict patients’ beliefs. Especially an increased concern about side effects could have influenced the adherence to biological treatment during the first lockdown. The primary objective was to investigate the impact of the first SARS-CoV-2 lockdown on adherence to biological treatm... Mehr ...

Verfasser: van der Groef, Romy
de Jong, Pascal H.P.
Hijnen, Dirk Jan
van der Woude, Christien J.
van Laar, Jan A.M.
van der Kuy, P. Hugo M.
Brugma, Jan Dietert
Pasma, Annelieke
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: van der Groef , R , de Jong , P H P , Hijnen , D J , van der Woude , C J , van Laar , J A M , van der Kuy , P H M , Brugma , J D & Pasma , A 2023 , ' Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands ' , Patient Preference and Adherence , vol. 17 , pp. 167-174 . https://doi.org/10.2147/PPA.S392290
Schlagwörter: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26840435
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://pure.eur.nl/en/publications/7c17018c-d8e9-44d2-8324-38374f7760ab